SORT BY

FILTER BY

fastest growing stats

also on other fortune lists

100 Fastest-Growing Companies

Doug Abdelnour

50

Regeneron Pharmaceuticals

REGN

With four FDA-approved drugs, this biotech firm based in Tarrytown, N.Y., has seen its share price surge as much as 40% this year.

Looking for leads, investment insights, or competitive intelligence?

Location

Tarrytown, N.Y.

Industry

Pharmaceuticals

Sector

Health Care

Current Streak

-

Years on List

1

CEO

Leonard Schleifer

Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
Regeneron Pharmaceuticals is also featured in these fortune lists
Revenue, Net Income
$ millions
Revenue past four quarters ($M)$4,979
Net Income past four quarters ($M)$963
Growth Rates and Ranks
Revenue 3 Yr Growth Rank45
Revenue 3 Yr Annual Growth Rate33%
EPS 3 Yr Growth Rank51
EPS 3 Yr Annual Growth Rate38%
Total Return 3 Yr Rank61
Total Return 3 Yr Annual Rate20%
Beat S&P 500 (9.6%)Yes
P/E Ratio45
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Regeneron Pharmaceuticals

Could a Vaccine Prevent High Cholesterol and Heart Disease?

Scientists are ready to move an experimental treatment into phase 1 trials.

Read More →
Trump's Proposed Science Cuts Could Devastate Future Generations, Pharma Expert Says

“We should only be working on two things, health and the freaking environment.”

Read More →
Pharma Executives Aren't Excited About Trump's Plans to Ease FDA Regulation

They say a robust review process is needed to convince doctors and insurers new drugs have value.

Read More →